<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - WCRX</title>
<description>International Business News - WCRX</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Earnings roundup: Nortel Networks, Cinemark</title>
  <description>Among the earnings stories for Monday, Nov. 10, from AP Financial News: Top stories:</description>
    <link>http://www.ibtimes.com/articles/20081110/earnings-roundup-nortel-networks-cinemark.htm</link> 
  <pubDate>Mon, 10 Nov 2008 10:43:49 EST</pubDate>
  </item>


  <item>
  <title>Outlook roundup: Brocade, Beazer Homes</title>
  <description>Among the earnings projection stories for Monday, Nov. 10, from AP Financial News: SAN JOSE, Calif. (AP)--Networking-gear maker Brocade Communications Systems Inc. raised its fiscal fourth-quarter adjusted profit and sales outlook despite the economic turmoil that has challenged many technology companies during the quarter.</description>
    <link>http://www.ibtimes.com/articles/20081110/outlook-roundup-brocade-beazer-homes.htm</link> 
  <pubDate>Mon, 10 Nov 2008 10:33:21 EST</pubDate>
  </item>


  <item>
  <title>Warner Chilcott 3Q profit surges on cost cutting</title>
  <description>The drugmaker Warner Chilcott Ltd. boosted its full-year profit guidance Monday as it continues to cut general and research and development costs. The company now expects profit between $1.38 and $1.43 per share, excluding charges and gains, up from prior guidance of $1.30 to $1.35 per share. It reaffirmed revenue between $935 million and $945 million.</description>
    <link>http://www.ibtimes.com/articles/20081110/warner-chilcott-3q-profit-surges-on-cost-cutting.htm</link> 
  <pubDate>Mon, 10 Nov 2008 08:57:37 EST</pubDate>
  </item>


  <item>
  <title>Warner Chilcott 3Q profit surges on cost cutting</title>
  <description>Warner Chilcott Ltd. said Monday its third-quarter profit surged, beating Wall Street estimates as the drug company continued to cut general and research and development expenses.</description>
    <link>http://www.ibtimes.com/articles/20081110/warner-chilcott-3q-profit-surges-on-cost-cutting.htm</link> 
  <pubDate>Mon, 10 Nov 2008 08:14:20 EST</pubDate>
  </item>


  <item>
  <title>Incyte rises after reporting psoriasis drug data</title>
  <description>Shares of Incyte Corp. rose Thursday after the biotechnology company reported positive results from two mid-stage trials of its psoriasis drug candidate INCB18424.</description>
    <link>http://www.ibtimes.com/articles/20080918/incyte-wavers-after-reporting-psoriasis-drug-data.htm</link> 
  <pubDate>Thu, 18 Sep 2008 18:56:08 EDT</pubDate>
  </item>


  <item>
  <title>Earnings roundup: Dionex, Kite Realty</title>
  <description>Among the earnings stories for Friday, Aug. 8, from AP Financial News: NEW YORK (AP)_ Shares of Dionex Corp. fell sharply Friday after the laboratory equipment maker reported better-than-expected fiscal fourth-quarter profit but set a weak profit outlook for the first quarter.</description>
    <link>http://www.ibtimes.com/articles/20080808/earnings-roundup-dionex-kite-realty.htm</link> 
  <pubDate>Fri, 08 Aug 2008 15:06:25 EDT</pubDate>
  </item>


  <item>
  <title>Sales, lower costs lift Warner Chilcott profit</title>
  <description>Drug maker Warner Chilcott Ltd. said Friday its profit more than quadrupled in the second quarter, as sales improved and expenses decreased. The Bermuda-based company's profit climbed to $33.6 million, or 13 cents per share, from $7.9 million, or 3 cents per share at the same time last year. Revenue edged up 3 percent, to $234.2 million from $227 million, as sales and prices for most of its top drugs improved.</description>
    <link>http://www.ibtimes.com/articles/20080808/sales-lower-costs-lift-warner-chilcott-profit.htm</link> 
  <pubDate>Fri, 08 Aug 2008 12:14:44 EDT</pubDate>
  </item>


  <item>
  <title>Warner Chilcott gets FDA OK for 150 mg acne drug</title>
  <description>Warner Chilcott Ltd. said Monday the Food and Drug Administration approved a 150 mg strength of Doryx delayed-release tablets as a treatment for severe acne.</description>
    <link>http://www.ibtimes.com/articles/20080623/warner-chilcott-gets-fda-ok-for-150-mg-acne-drug.htm</link> 
  <pubDate>Mon, 23 Jun 2008 08:39:34 EDT</pubDate>
  </item>


  <item>
  <title>Outlook roundup: Central Vermont Public Service, Cogent</title>
  <description>Among the earnings projection stories for Friday, May 9, from AP Financial News: RUTLAND, Vt. (AP) _ Central Vermont Public Service Corp. affirmed its 2008 earnings guidance on Friday, after saying first-quarter earnings rose nearly 4 percent, despite a slight decline in retail revenue.</description>
    <link>http://www.ibtimes.com/articles/20080509/outlook-roundup-central-vermont-public-service-cogent.htm</link> 
  <pubDate>Fri, 09 May 2008 16:08:34 EDT</pubDate>
  </item>


  <item>
  <title>Warner Chilcott raises profit outlook on lower expenses</title>
  <description>Drug maker Warner Chilcott Ltd. raised its full-year profit outlook Friday, citing lower expenses and a lower expected tax rate. The company now expects profit between $1.30 and $1.35 per share, up from prior guidance of $1.25 to $1.30 per share. Warner Chilcott reaffirmed revenue guidance of $935 million to $945 million.</description>
    <link>http://www.ibtimes.com/articles/20080509/warner-chilcott-raises-profit-outlook-on-lower-expenses.htm</link> 
  <pubDate>Fri, 09 May 2008 11:09:55 EDT</pubDate>
  </item>


</channel>
</rss>